MedTrace Logo

Bupivacaine With Dexmedetomidine Versus Bupivacaine Alone for Transversus Abdominis Plane Block in Caesarean Section

NCT06292273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-05

No results posted yet for this study

Summary

Transversus Abdominis plane (TAP) block is a regional technique for providing analgesia of the anterolateral abdominal wall. TAP block are commonly given in patients who have undergone various abdominal as well as pelvic surgeries such as caesarean section, hysterectomy, appendicectomy and various laparoscopic surgeries. this study is conducted to analyse the effect of addition of dexmedetomidine to bupivacaine in Transversus Abdominis Plane (TAP) block.

Conditions

  • Post Operative Pain

Interventions

PROCEDURE

Transversus Abdominis Plane Block with bupivacain Plus dexamethasone

Bupivacain 0.1%, 35 ml with dexmedetomidine 0.5 µG/kg on each side

PROCEDURE

Transversus Abdominis Plane Block with bupivacain

plain bupivacaine 0.25%, 25 ml bilaterally

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • rabab M habeeb · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-10
Primary Completion
2024-02-01
Completion
2024-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06292273 on ClinicalTrials.gov